The forecast data indicates that the standardized rate of male tuberculosis mortality in Canada is expected to decrease significantly from 200 deaths per hundred thousand in 2024 and 2025 to 100 deaths per hundred thousand from 2026 to 2028. This represents a 50% decrease expected to commence in 2026. Prior to these forecasted years, the actual number of deaths in 2023 was stable at similar figures to those seen in 2024 and 2025.
The projected compound annual growth rate (CAGR) indicates an average annual reduction in male tuberculosis mortality rates over the five-year period from 2024 to 2028. Key trends to monitor include advancements in public health initiatives, potential vaccine developments, and changes in healthcare policy that could further influence the decline in tuberculosis mortality rates. Watch for emerging technologies and global health partnerships as they play critical roles in addressing tuberculosis challenges.
